Payers worldwide are struggling with a new generation of precision medicines that come with a hefty price tag. Ben Hargreaves finds that the UK’s NICE is once again caught between ensuring ...
Barbara Friedberg is a veteran investment portfolio manager, fintech consultant, and expert investor. She is a published author of several books. Suzanne is a content marketer, writer, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results